MYO - Myomo, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
0.4913
-0.0026 (-0.53%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close0.4939
Open0.0000
Bid0.0000 x 3000
Ask0.0000 x 1800
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume61,992
Market Cap8.45M
Beta (3Y Monthly)0.94
PE Ratio (TTM)N/A
EPS (TTM)-0.6900
Earnings DateNov 12, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.02
  • Myomo, Inc. (MYO) Reports Q3 Loss, Misses Revenue Estimates
    Zacks

    Myomo, Inc. (MYO) Reports Q3 Loss, Misses Revenue Estimates

    Myomo, Inc. (MYO) delivered earnings and revenue surprises of 0.00% and -53.31%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Business Wire

    Myomo Reports Third Quarter 2019 Results

    Growth Metrics Accelerating; Timing of Insurance Payments Affecting Short-term Revenue Growth

  • Business Wire

    Myomo to Report Third Quarter 2019 Results on November 12, 2019

    Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will release its financial results for the third quarter ended September 30, 2019 on Tuesday, November 12, 2019, after the market close. The Company will host a conference call the same day, Tuesday, November 12, 2019 at 4:30 p.m. ET with prepared remarks by Paul R. Gudonis, Chairman and Chief Executive Officer, and David Henry, Chief Financial Officer. The conference call webcast can be accessed through Myomo’s Investor Relations page at http://ir.myomo.com/.

  • Myomo, Inc. (MYO) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
    Zacks

    Myomo, Inc. (MYO) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

    Myomo, Inc. (MYO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Business Wire

    Myomo Closes $3M Term Loan

    Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has entered into a term loan agreement with Chicago Venture Partners (CVP) for $3 million. Myomo expects to use the proceeds to continue to grow the company’s pipeline of qualified MyoPro candidates, introduce the new pediatric version of its MyoPro orthosis, and for general corporate purposes.

  • Business Wire

    Myomo Announces Departure of Steve Sanghi from Board of Directors

    Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced the resignation of Steve Sanghi from its Board of Directors to focus on his duties as CEO and Board Chairman of Microchip Technology Inc. He will continue to serve as an advisor to Myomo and remain a personal investor in the company.

  • Here's Why We're A Bit Worried About Myomo's (NYSEMKT:MYO) Cash Burn Situation
    Simply Wall St.

    Here's Why We're A Bit Worried About Myomo's (NYSEMKT:MYO) Cash Burn Situation

    There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

  • GNC Holdings Inks Retail Partnership Deal to Grow in Brazil
    Zacks

    GNC Holdings Inks Retail Partnership Deal to Grow in Brazil

    We consider this corporate deal in Brazil to be a strategic fit for GNC Holdings (GNC), which currently pulls out all the stops to fortify its global footprint.

  • Innovation Aids Genomic Health, Merger Procedure on Track
    Zacks

    Innovation Aids Genomic Health, Merger Procedure on Track

    Genomic Health (GHDX) is on course to realize its impending merger with cancer diagnostics major Exact Sciences, which will integrate brands like Cologuard and OncotypeDX.

  • Insulet (PODD) Scales 52-Week High: What's Driving the Stock?
    Zacks

    Insulet (PODD) Scales 52-Week High: What's Driving the Stock?

    Insulet (PODD) has various favorable factors to maintain the current high.

  • Before You Buy Myomo, Inc. (NYSEMKT:MYO), Consider Its Volatility
    Simply Wall St.

    Before You Buy Myomo, Inc. (NYSEMKT:MYO), Consider Its Volatility

    If you own shares in Myomo, Inc. (NYSEMKT:MYO) then it's worth thinking about how it contributes to the volatility of...

  • Will Myomo, Inc. (MYO) Report Negative Q2 Earnings? What You Should Know
    Zacks

    Will Myomo, Inc. (MYO) Report Negative Q2 Earnings? What You Should Know

    Myomo, Inc. (MYO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • If You Had Bought Myomo (NYSEMKT:MYO) Stock A Year Ago, You'd Be Sitting On A 73% Loss, Today
    Simply Wall St.

    If You Had Bought Myomo (NYSEMKT:MYO) Stock A Year Ago, You'd Be Sitting On A 73% Loss, Today

    Even the best investor on earth makes unsuccessful investments. But serious investors should think long and hard about...

  • Business Wire

    Myomo Announces First Insurance Reimbursements in European Markets

    Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, announced today that its Orthotics and Prosthetics (O&P) distribution partners in Germany and Denmark have successfully obtained their first reimbursement decisions by insurance payers for the MyoPro orthosis. In addition, these O&P providers, along with other certified firms in the UK and Italy, have a growing number of MyoPro units in the reimbursement process.

  • What Percentage Of Myomo, Inc. (NYSEMKT:MYO) Shares Do Insiders Own?
    Simply Wall St.

    What Percentage Of Myomo, Inc. (NYSEMKT:MYO) Shares Do Insiders Own?

    The big shareholder groups in Myomo, Inc. (NYSEMKT:MYO) have power over the company. Large companies usually have...

  • Business Wire

    Myomo® Announces Participation in Beijing Trade Show

    Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, announces its participation in the China International Fair for Trade in Services, to be held in Beijing from May 28-31, 2019. Myomo will participate in this event together with Beijing Ryzur Medical Investment Co., Ltd. (Ryzur Medical), a growing medical device manufacturer based in Beijing.

  • Myomo, Inc. (MYO) Reports Q1 Loss, Lags Revenue Estimates
    Zacks

    Myomo, Inc. (MYO) Reports Q1 Loss, Lags Revenue Estimates

    Myomo, Inc. (MYO) delivered earnings and revenue surprises of 15.00% and -3.49%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Business Wire

    Myomo Reports First Quarter 2019 Results

    Reports 165% Year-over-Year Revenue Growth and Continued Expansion of Reimbursement Pipeline

  • Business Wire

    Myomo to Report First Quarter 2019 Results on May 13, 2019

    Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will release its financial results for the first quarter ended March 31, 2019 on Monday, May 13, 2019, before the US markets open. The Company will host a conference call on Monday, May 13, 2019 at 8:30 a.m. EDT featuring remarks by Paul R. Gudonis, Chairman and Chief Executive Officer, and David Henry, Chief Financial Officer.

  • Myomo, Inc. (MYO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
    Zacks

    Myomo, Inc. (MYO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

    Myomo, Inc. (MYO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.